
Leveraging CRM Data in the Pharma World: the Key to become a Data-Driven Company
Turn CRM into a strategic lever in Pharma: analyze data to drive decisions, optimize the field force, and personalize sales and marketing strategies.
Home » Life Science

Turn CRM into a strategic lever in Pharma: analyze data to drive decisions, optimize the field force, and personalize sales and marketing strategies.

Did you know that the medicine you buy at the pharmacy might have traveled across half of Europe before reaching you? Welcome to the complex

At the Data Management Summit 2025, Angelini Pharma and Blue BI presented their journey toward digital excellence. They illustrated how Angelini Pharma has evolved into a data-driven organization using a hybrid data platform and highlighted the importance of data governance for generative AI.

Blue BI’s application optimizes the process of managing sales incentives in the pharmaceutical sector, automating bonus calculations and boosting efficiency and transparency.

Blue BI developed an automated platform for credit management in the pharmaceutical sector, integrating data from ERP and CRM to monitor revenue, credit, and financial exposure in real time. The automation enables accurate forecasting, “what if” analysis, and centralized management, improving operational efficiency and reducing the risk of error.

In the pharmaceutical industry, a deep digitalization process is underway that has prompted organizations to review their business strategies and adopt an increasingly data-oriented approach. This Case Study describes an important project developed by Blue BI for customer Angelini Pharma, which aims to centralize most of the digital activity analysis a user may need.

The future of the Life Science and Healthcare industry hinges on the management of Big Data, used for predictive and prescriptive purposes. What are the challenges and benefits?

Big Data, Artificial Intelligence and Machine Learning represent a great opportunity for the Life Science sector, both for industries and for patients. We’ll talk about it here.
